SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING for SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Nuclear medicine reimbursement generally and under HOPPS and MPFS specifically. Sustainable growth rate (SGR) physician payment reform generally.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSAN KATHLEEN BUNNING | — |
| JESSE SCHOOLNIK | — |
Budget/Appropriations BUD
FY '14 (S. 1245, and HR 2609) Energy/Water Appropriations regarding Department of Energy funding opportunities for nuclear medicine research (Title III) FY '14 Labor/HHS/Education appropriations regarding National Institute of Biomedical Imaging and Bioengineering funding opportunities for nuclear medicine research.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSAN KATHLEEN BUNNING | — |
| JESSE SCHOOLNIK | — |
Energy/Nuclear ENG
Domestic isotope supply issues, including the American Medical Isotopes Production Act of 2011. Medical radiation issues generally, including Nuclear Regulatory Commission regulations.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSAN KATHLEEN BUNNING | — |
| JESSE SCHOOLNIK | — |
Pharmacy PHA
Pharmacy compounding of radiopharmaceuticals; The Drug Quality and Security Act (H.R. 3204).
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSAN KATHLEEN BUNNING | — |
| JESSE SCHOOLNIK | — |
Health Issues HCR
Consistency, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy Act of 2011 (H.R. 1146 and S. 642); implementation of the Affordable Care Act generally.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSAN KATHLEEN BUNNING | — |
| JESSE SCHOOLNIK | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.